Theorem Clinical Research

AMRI

AMRI hires Jimmy Wang as chief information officer

Wednesday, February 11, 2015 02:46 PM

Albany Molecular Research (AMRI), a global contract research and manufacturing organization, has hired Jimmy Wang, Ph.D., to fill the newly created position of chief information officer, effective immediately. He replaces Carl Neumann, senior director, information technology, who retires this month.

More... »

Quest Diagnostics

AMRI announces CFO transition

Friday, January 16, 2015 10:50 AM

Michael M. Nolan, senior vice president and chief financial officer, will be departing Albany Molecular Research (AMRI), a global contract research and manufacturing organization. Nolan will remain with AMRI through February 2015 to support an orderly transition. Felicia Ladin will join the company in the same role, effective Feb. 4, 2015.

More... »


AMRI to acquire Aptuit drug development, aseptic manufacturing businesses

Friday, January 9, 2015 02:01 PM

Albany Molecular Research (AMRI), a global contract research and manufacturing organization, has acquired the outstanding equity interests of Aptuit's Glasgow, U.K., business and has entered into a definitive agreement to acquire Aptuit's SSCI/West Lafayette, Ind., business, for a total of $60 million, expanding AMRI's drug product development and aseptic clinical manufacturing capabilities.

More... »

AMRI's expands discovery biology offerings

Monday, September 8, 2014 01:52 PM

Albany Molecular Research (AMRI), a New York-based global CRO, has expanded into the protein market, with an initial focus on protein expression and purification. The global revenue of the total proteomics market is anticipated to grow at a compound annual growth rate of about 4.1% to about $9.2 billion by 2018.

More... »

AMRI completes acquisition of Oso Biopharmaceuticals Manufacturing

Friday, July 4, 2014 10:00 PM

Albany Molecular Research (AMRI), a global contract research and manufacturing organization, has completed the acquisition of Oso Biopharmaceuticals Manufacturing, a former portfolio company of Altaris Capital Partners.

More... »

AMRI to acquire OsoBio

Monday, June 2, 2014 01:13 PM

Albany Molecular Research (AMRI), a global contract research and manufacturing organization, has signed a definitive agreement to acquire all outstanding membership interests of Oso Biopharmaceuticals Manufacturing (OsoBio) for $110 million in cash.

More... »

AMRI shutters New York research center, cuts 45 jobs

Friday, April 18, 2014 12:39 PM

Albany Molecular Research (AMRI), a global contract research and manufacturing organization, will be transitioning Discovery and Development Services (DDS) activities at its Syracuse, N.Y., site to other sites within AMRI and will cease operations in Syracuse by the end of June.

More... »

AMRI to acquire Cedarburg Pharmaceuticals

Monday, March 24, 2014 02:42 PM

Albany Molecular Research (AMRI), a global contract research and manufacturing organization based in Albany, N.Y., will acquire all outstanding shares of Cedarburg Pharmaceuticals for $38.2 million in cash. The transaction, including $2.8 million of assumed liabilities, is valued at $41 million.

More... »

AMRI Hires Vijay Kumar Batra as Managing Director, AMRI India

Wednesday, January 15, 2014 07:52 AM

Albany Molecular Research, a global contract research and manufacturing organization, has appointed Vijay Kumar Batra to managing director, AMRI India, effective Jan. 2. Batra will report to Steve Hagen, Ph.D., senior vice president of manufacturing and pharmaceuticals.

More... »

AMRI announces lifting of FDA warning letter

Wednesday, November 13, 2013 09:27 AM

Albany, N.Y.-based Albany Molecular Research (AMRI) has received a close-out letter from the FDA lifting a 2010 warning letter related to its Burlington, Mass., aseptic fill-and-finish facility.

More... »


CWWeekly

March 2

Huntingdon Life Sciences-Harlan prepares for rebranding and U.S. expansion to compete with early phase CROs Covance, CRL

Patients' increased sharing of clinical trial experiences through social media can help sponsors improve outcomes, enrollment

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs